Graham M. Lord

19.7k total citations · 5 hit papers
136 papers, 12.4k citations indexed

About

Graham M. Lord is a scholar working on Immunology, Epidemiology and Surgery. According to data from OpenAlex, Graham M. Lord has authored 136 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Immunology, 20 papers in Epidemiology and 19 papers in Surgery. Recurrent topics in Graham M. Lord's work include Immune Cell Function and Interaction (61 papers), T-cell and B-cell Immunology (43 papers) and IL-33, ST2, and ILC Pathways (19 papers). Graham M. Lord is often cited by papers focused on Immune Cell Function and Interaction (61 papers), T-cell and B-cell Immunology (43 papers) and IL-33, ST2, and ILC Pathways (19 papers). Graham M. Lord collaborates with scholars based in United Kingdom, United States and Italy. Graham M. Lord's co-authors include Robert I. Lechler, Giuseppe Matarese, Jane K. Howard, Stephen R. Bloom, Laurie H. Glimcher, Richard J. Baker, Veronica Sanna, Silvia Fontana, Behdad Afzali and Ian Jackson and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Graham M. Lord

133 papers receiving 12.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression

1998 1.8k citations Graham M. Lord, Giuseppe Matarese et al. profile →
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency

2002 1.0k citations I. Sadaf Farooqi, Giuseppe Matarese et al. Journal of Clinical Investigation profile →
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency

2002 854 citations I. Sadaf Farooqi, Giuseppe Matarese et al. Journal of Clinical Investigation profile →
Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System

2007 714 citations Graham M. Lord et al. profile →
The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease

2007 607 citations Behdad Afzali, Robert I. Lechler et al. Clinical & Experimental Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Graham M. Lord United Kingdom	51	4.9k	3.4k	3.2k	2.5k	2.0k	136	12.4k
Giuseppe Matarese Italy	66	5.7k 1.2×	6.0k 1.8×	5.9k 1.8×	4.4k 1.8×	3.0k 1.5×	215	18.5k
Giamila Fantuzzi United States	64	6.5k 1.3×	5.6k 1.6×	2.3k 0.7×	3.5k 1.4×	7.0k 3.4×	198	19.6k
Juan J. Gómez‐Reino Spain	72	5.3k 1.1×	4.0k 1.2×	1.3k 0.4×	2.0k 0.8×	2.5k 1.2×	364	19.8k
Dennis D. Taub United States	76	7.5k 1.5×	2.3k 0.7×	1.8k 0.5×	2.7k 1.1×	4.5k 2.2×	235	17.9k
Zamir Halpern Israel	52	1.5k 0.3×	3.6k 1.1×	820 0.3×	2.2k 0.9×	3.7k 1.8×	244	12.7k
Christoph A. Thaiss United States	40	3.1k 0.6×	2.5k 0.7×	831 0.3×	3.3k 1.3×	9.1k 4.4×	79	15.4k
Katsumi Eguchi Japan	72	3.4k 0.7×	3.3k 1.0×	510 0.2×	1.9k 0.8×	3.3k 1.6×	714	19.7k
C A Dinarello United States	65	7.1k 1.5×	2.7k 0.8×	478 0.1×	1.9k 0.8×	3.8k 1.9×	138	16.3k
Heinz Baumann United States	39	2.3k 0.5×	1.4k 0.4×	928 0.3×	1.1k 0.5×	2.2k 1.1×	75	8.1k
Michael J. Holtzman United States	72	5.0k 1.0×	2.4k 0.7×	577 0.2×	4.4k 1.8×	3.2k 1.6×	226	15.1k

Countries citing papers authored by Graham M. Lord

Since Specialization

Citations

This map shows the geographic impact of Graham M. Lord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham M. Lord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham M. Lord more than expected).

Fields of papers citing papers by Graham M. Lord

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham M. Lord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham M. Lord. The network helps show where Graham M. Lord may publish in the future.

Co-authorship network of co-authors of Graham M. Lord

This figure shows the co-authorship network connecting the top 25 collaborators of Graham M. Lord. A scholar is included among the top collaborators of Graham M. Lord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham M. Lord. Graham M. Lord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Clough, Jennifer, Joana C. Vasconcelos, James B. Canavan, et al.. (2025). Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE). BMJ Open. 15(1). e092733–e092733. 5 indexed citations

2.

Lo, Jonathan W., Luke B. Roberts, Domenico Cozzetto, et al.. (2024). CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner. Nature Communications. 15(1). 9520–9520. 6 indexed citations

3.

Stolarczyk, Émilie, Chi Teng Vong, Natividad Garrido‐Mesa, et al.. (2024). Global deletion of the immune cell transcription factor, T-bet, alters gut microbiota and insulin sensitivity in mice. Frontiers in Genetics. 15. 1502832–1502832. 1 indexed citations

4.

Lo, Jonathan W., Domenico Cozzetto, James L. Alexander, et al.. (2023). Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis. Nature Communications. 14(1). 6719–6719. 15 indexed citations

5.

Goldberg, Rimma, Jennifer Clough, Luke B. Roberts, et al.. (2021). A Crohn’s Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 Signalling. Journal of Crohn s and Colitis. 15(12). 2054–2065. 5 indexed citations

6.

Roberts, Luke B., et al.. (2021). An update on the roles of immune system-derived microRNAs in cardiovascular diseases. Cardiovascular Research. 117(12). 2434–2449. 9 indexed citations

7.

Roberts, Luke B., Geraldine M. Jowett, Emily Read, et al.. (2021). MicroRNA-142 Critically Regulates Group 2 Innate Lymphoid Cell Homeostasis and Function. The Journal of Immunology. 206(11). 2725–2739. 10 indexed citations

8.

Clough, Jennifer, et al.. (2020). Regulatory T-cell therapy in Crohn’s disease: challenges and advances. Gut. 69(5). 942–952. 124 indexed citations

9.

Roberts, Luke B., Joanna Willis, Padmini Sarathchandra, et al.. (2020). Dominant regulation of long-term allograft survival is mediated by microRNA-142. American Journal of Transplantation. 20(10). 2715–2727. 9 indexed citations

10.

Villegas-Méndez, Ana, Garima Khandelwal, Michael Haley, et al.. (2020). Exhausted CD4+ T Cells during Malaria Exhibit Reduced mTORc1 Activity Correlated with Loss of T-bet Expression. The Journal of Immunology. 205(6). 1608–1619. 15 indexed citations

11.

Goldberg, Rimma, Natalie J. Prescott, Graham M. Lord, Thomas T. MacDonald, & Nick Powell. (2015). The unusual suspects—innate lymphoid cells as novel therapeutic targets in IBD. Nature Reviews Gastroenterology & Hepatology. 12(5). 271–283. 77 indexed citations

12.

Willis, Joanna & Graham M. Lord. (2015). Immune biomarkers: the promises and pitfalls of personalized medicine. Nature reviews. Immunology. 15(5). 323–329. 70 indexed citations

13.

Canavan, James B., Behdad Afzali, Cristiano Scottà, et al.. (2012). A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy. Blood. 119(8). e57–e66. 61 indexed citations

14.

Soderquest, Katrina, Nick Powell, Carmelo Luci, et al.. (2011). Monocytes control natural killer cell differentiation to effector phenotypes. Blood. 117(17). 4511–4518. 72 indexed citations

15.

Suddason, Tesha, et al.. (2009). Translational Mini-Review Series on Th17 Cells: Development of mouse and human T helper 17 cells. Clinical & Experimental Immunology. 159(2). 148–158. 53 indexed citations

16.

Farooqi, I. Sadaf, Giuseppe Matarese, Graham M. Lord, et al.. (2002). Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation. 110(8). 1093–1103. 854 indexed citations breakdown →

17.

Farooqi, I. Sadaf, Giuseppe Matarese, Graham M. Lord, et al.. (2002). Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation. 110(8). 1093–1103. 108 indexed citations

18.

Matarese, Giuseppe, Antonio Di Giacomo, Veronica Sanna, et al.. (2001). Requirement for Leptin in the Induction and Progression of Autoimmune Encephalomyelitis. The Journal of Immunology. 166(10). 5909–5916. 291 indexed citations

19.

Lord, Graham M.. (1997). James Herriot: The Life of a Country Vet. Expert Review of Anti-infective Therapy. 2(4). 625–39. 1 indexed citations

20.

Hagis, Peter & Graham M. Lord. (1977). Quasi-Amicable Numbers. Mathematics of Computation. 31(138). 608–608. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact